Maegim

Stock search

Search by company name, 6-digit code, or Korean initials (e.g. ㅅㅅㅈㅈ)

☆한국어

Celltrion, Inc.

셀트리온068270KOSPISector: Pharma & Biotech
₩188,1000.53%Market cap ₩43.76TAs of Sep 4, 2026 close · updated once daily
Market cap
₩43.76T
#17 in KOSPI
42.5x
Sector median 15.7x (profitable cos.)
2.54x
Sector median 1.59x
0.0%
Sector median 0.0%
A
Grade A65.3 ptsTop 21% of 2,522 graded stocksMethodology v2.0
Financial strength
70.5/100
Growth momentum
82.4/100
Price attractiveness
51.4/100
Shareholder Return
37.5/100

As of Sep 4, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

How to read this grade
SACurrentBCDF

Toward S means a higher total-score band; toward F, a lower band. Badges are distinguished by ink intensity and shape (fill, outline, dashed) — never by hue.

Maegim maps a total score — built from sector-relative percentile scoring — onto fixed, predefined thresholds to assign one of six bands, S to F. This stock is scored by the same formula as all 2,522 graded stocks and is currently in band A with a total score of 65.3 points.

How grades are computed →What grades do and don’t mean →What the grade does not reflect →

Position within sector

Mechanically selected indicators in the top or bottom 30% of sector percentiles · among 250 stocks in Pharma & Biotech

1-year closing price

Loading closing price history…
 
Low ₩159,400High ₩248,500
Latest close
Price change by period
1W
1.30%
1M
1.20%
3M
6.50%
1Y
10.50%

As of the Sep 4, 2026 close · updated once daily · a factual record computed from closing prices only; dividends are not included, and this is not a buy or sell signal.

1

Financial strength

70.5/100
How much debt does it carry relative to equity?
28.7%
Sector median 51.6%
Sector lowhighTop 28.1% in sector
Can it cover what's due within a year?
139.3%
Sector median 191.7%
Sector lowhighBottom 39.9% in sector
How much of revenue becomes profit?
28.1%
Sector median -2.4%
Sector lowhighTop 5.1% in sector
How much did it earn on its own capital?
6.0%
Sector median -4.5%
Sector lowhighTop 24.9% in sector

Source filing: annual report (consolidated) — view original ↗

2

Growth momentum

82.4/100
How much did revenue grow in a year?
17.0%
Sector median 6.4%
Sector lowhighTop 26.6% in sector
Has it grown steadily over three years?
22.1%
Sector median 4.9%
Sector lowhighTop 11.8% in sector
Did core profits grow in a year?
137.5%
Sector median 3.6%
Sector lowhighTop 10.9% in sector
Are core profits higher than three years ago?
80.5%
Sector median 3.5%
Sector lowhighTop 21.2% in sector

Financial trend

Revenue

Growth & margin

Revenue growth Operating margin

Year over year — alongside the sector median

This stock Sector median

A factual chart of confirmed annual results from annual reports — the same source as the grading indicators. Not a buy or sell signal.

Source filing: annual report (consolidated) — view original ↗

3

Price attractiveness

51.4/100
Is the price expensive relative to earnings?
42.5x
Sector median P/E of profitable peers 15.7x · 58% loss-making
Sector lowhighTop 34.6% in sector
Is the price expensive relative to book value?
2.54x
Sector median 1.59x
Sector lowhighBottom 37.4% in sector

Valuation uses the Sep 4, 2026 close and market cap

4

Shareholder Return

Single-indicator axis37.5/100
Does the company actually pay dividends?
0.0%
Sector median 0.0%
Sector lowhighBottom 37.5% in sector

Dividend per share (annual)

Cash dividend per common share as stated in annual reports. ₩0 means no dividend that year.

Dividends & treasury shares

Total cash dividends (FY2025)
₩164.0B
Cash payout ratio, consolidated (FY2025)
15.9%
Treasury shares (FY2023)
13,082,991 shares (5.9% of shares issued)

Source: annual report (DART) — dividend allocation & total shares

Source filing: annual report (consolidated) — view original ↗

Financial checklist

Based on the FY2025 annual report · year-over-year comparison · determined on Sep 7, 2026

Of 9 items: 5 met · 3 not met · 1 not computable

Not metMetNot computable

Positive net income
Whether net income (attributable to owners where available) is above zero.
Met
₩1T
Positive operating cash flow
Whether cash flow from operations is above zero.
Met
₩646.1B
Return on assets up
Whether net income over beginning total assets rose from the prior year.
Met
2.1% → 4.9%
Operating cash flow exceeds net income
Whether operating cash flow is greater than net income.
Not met
₩646.1B vs ₩1T
Liabilities-to-assets ratio down
Whether total liabilities as a share of total assets fell from the prior year.
Not met
16.5% → 22.3%
Current ratio up
Whether current assets over current liabilities rose from the prior year.
Not met
175.2% → 139.3%
Shares outstanding not increased
Whether common shares issued did not increase from the prior year. Increases from bonus issues and stock dividends are also counted.
Not computable

Not computed — share count data is unavailable

Operating margin up
Whether operating income over revenue rose from the prior year.
Met
13.8% → 28.1%
Asset turnover up
Whether revenue over beginning total assets rose from the prior year.
Met
0.18x → 0.20x

A record of facts determined by fixed rules from the financial statements in the latest annual report. Not used in grading, and not a buy or sell signal. Source filing: annual report (consolidated) — view original ↗

Grade change history

Jul 23, 2026A

Methodology version change (v2.0 applied)

Jul 15, 2026AVersion v1

First calculation

Grade changes are a factual record produced from public data by a fixed formula; they do not signal future changes.

Disclosure & financial badges

Factual records determined from public filings and periodic reports by fixed rules — not buy/sell signals.

Negative-evidence group (dilution, loss, dispute)Mixed interpretationPositive-evidence group (shareholder return)Dots classify the disclosure type by the direction of research evidence — not an assessment or investment judgment about this company.

Disclosure event history

Corporate value-up plan filed

Filed a “기업가치제고계획(자율공시)” (corporate value-up plan, voluntary disclosure) (filed 2026-03-24). View filing ↗

Treasury share cancellation

Cancelled 4,970,950 treasury shares in FY2025 (per annual report). View filing ↗

Management-dispute lawsuit filing

A filing under the KRX form “소송등의제기ㆍ신청(경영권분쟁소송)” (filing/petition of lawsuit — management dispute) was received (received 2025-12-18). View filing ↗

Determined as of 2026-09-07

Recent filings for this stock

Last 120 days · monitored filing types only
Treasury stock acquisitionAug 31, 2026Source ↗
Periodic report filedAug 14, 2026Source ↗
Treasury stock acquisitionMay 21, 2026Source ↗
Periodic report filedMay 15, 2026Source ↗

View in the filings calendar →